Indication: Treatment of invasive aspergillosis. Treatment of severe invasive infections caused by Candida species resistant to fluconazole (including Candida krusei). Treatment of severe infections caused by Actinomyces and Fusarium species. This product should be used primarily to treat progressive, potentially life-threatening infections in immunocompromised patients.

Indication: This product is used to treat invasive aspergillosis, severe invasive candidiasis infections resistant to fluconazole (including Candida krusei), and severe fungal infections caused by Actinomyces and Fusarium. It is mainly used for patients with progressive, life-threatening immune damage.

Indication: This product is a broad-spectrum triazole antifungal drug with the following indications: Treatment of invasive aspergillosis. Treatment of severe invasive infections caused by Candida species resistant to fluconazole (including Candida krusei). Treatment of severe infections caused by Actinomyces and Fusarium species. This product should be used primarily to treat progressive, potentially life-threatening infections in immunocompromised patients.

Indication: This product is a broad-spectrum triazole antifungal drug with the following indications: Treatment of invasive aspergillosis. Treatment of severe invasive infections caused by Candida species resistant to fluconazole (including Candida krusei). Treatment of severe infections caused by Actinomyces and Fusarium species. This product should be used primarily to treat progressive, potentially life-threatening infections in immunocompromised patients.

Indication: This product is used to treat invasive aspergillosis, severe invasive candidiasis infections resistant to fluconazole (including Candida krusei), and severe fungal infections caused by Actinomyces and Fusarium. It is mainly used for patients with progressive, life-threatening immune damage.

Indication: This product is a broad-spectrum triazole antifungal drug with the following indications: Treatment of invasive aspergillosis. Treatment of candidemia in non-neutropenic patients. Treatment of severe invasive infections caused by Candida species resistant to fluconazole (including Candida krusei). Treatment of severe infections caused by Actinomyces and Fusarium species. This product should be used primarily to treat patients with progressive, potentially life-threatening infections.

Indication: 1. Gynecology: vulvovaginal candidiasis. 2. Dermatology/ophthalmology: tinea versicolor, dermatophytes, fungal keratitis and oral candidiasis. 3. Onychomycosis caused by dermatophytes and/or yeasts. 4. Systemic fungal infections: systemic aspergillosis and candidiasis, cryptococcosis (including cryptococcal meningitis), histoplasmosis, sporotrichosis, paracoccidioidomycosis, blastomycosis and various other rare systemic or tropical fungal diseases.

Indication: 1. Gynecology: vulvovaginal candidiasis; 2. Dermatology/ophthalmology: tinea versicolor, dermatophytes, fungal keratitis and oral candidiasis. Onychomycosis caused by dermatophytes and/or yeasts; 3. Systemic fungal infections: systemic aspergillosis and candidiasis, cryptococcosis (including cryptococcal meningitis), histoplasmosis, sporotrichosis (including cryptococcal meningitis), histoplasmosis, sporotrichosis, Brazilian paracoccidioidomycosis, blastomycosis and various other rare systemic or tropical fungal diseases.

Indication: This product can be used for empirical treatment of patients with neutropenia and fever suspected of fungal infection. This product can also be used to treat the following systemic fungal infections: 1. Aspergillosis. 2. Candidiasis. 3. Cryptococcal disease (including cryptococcal meningitis); for immunocompromised patients with cryptococcosis and all patients with central nervous system cryptococcosis, this product can only be used for treatment when first-line drugs are not applicable or ineffective; 4. Histoplasmosis. Before treatment, fungal specimens should be collected and other relevant laboratory tests (wet smears, histopathology, serology) should be performed to isolate and identify pathogenic microorganisms. Treatment can be carried out before the results of culture and other laboratory tests are obtained; once meaningful test results are obtained, antifungal treatment should be adjusted accordingly.